Intravitreal aflibercept injection in Indian eyes with retinopathy of prematurity
Purpose: To study the efficacy of intravitreal Aflibercept, an anti Vascular Endothelial Growth factor, (anti-VEGF) in Retinopathy of Prematurity (ROP). Methods: This was a retrospective, interventional consecutive case series of 46 Indian eyes which received intravitreal injection of Aflibercept fo...
Main Author: | Vasumathy Vedantham |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Indian Journal of Ophthalmology |
Subjects: | |
Online Access: | http://www.ijo.in/article.asp?issn=0301-4738;year=2019;volume=67;issue=6;spage=884;epage=888;aulast=Vedantham |
Similar Items
-
Comparison of aflibercept and bevacizumab in the treatment of type 1 retinopathy of prematurity
by: Hamid Riazi-esfahani, et al.
Published: (2021-10-01) -
Hypertension and Ischemic Stroke After Aflibercept for Retinopathy of Prematurity
by: Bazvand F, et al.
Published: (2020-07-01) -
Effect and factors associated with reactivation after intravitreal conbercept or aflibercept in retinopathy of prematurity
by: Chunling Huang, et al.
Published: (2025-01-01) -
Efficacy of intravitreal injection of Ziv-aflibercept before vitrectomy for proliferative diabetic retinopathy
by: Amin E. Nawar, et al.
Published: (2024-04-01) -
Intravitreal ranibizumab for postlaser anterior segment ischemia in retinopathy of prematurity
by: Vasumathy Vedantham
Published: (2022-01-01)